Research is being conducted on optimizing androgen signaling blockade in high-risk prostate cancer, with some studies focusing on hormone therapy and its potential duration. The use of triple therapy and therapeutic sequencing in metastatic prostate cancer is also being explored. Additionally, innovations in screening, diagnosis, and treatment approaches, including the potential role of artificial intelligence, are being reviewed and discussed in the context of prostate cancer management.